Axel Lehrer, Ph.D.
Assistant Professor Department of Tropical Medicine, Medical Microbiology and Pharmacology John A. Burns School of Medicine
Phone:
Office: BSB 320B
Email: lehrer [at] hawaii.edu
Bio
Education
|
|
|
1998 |
M.Sc. |
(Biochemistry) University of Bayreuth, Germany |
2001 |
Ph.D. |
(Biology) University of Bayreuth, Germany |
Specialization:Vaccinology, Molecular Virology Professional Memberships
|
|
2011-present |
American Society of Microbiology |
2002-present |
American Society for Biochemistry and Molecular Biology |
2004-2010 |
American Society for Tropical Medicine and Hygiene |
Research Keywords: Ebola, filoviruses
Selected Publications
-
Haun BK, Kamara V, Dweh AS, Garalde-Machida K, Forkay SSE, Takaaze M, Namekar M, Wong TAS, Bell-Gam Woto AER, Humphreys P, Weeks OI, Fallah MP, Berestecky JM, Nerurkar VR, Lehrer AT.
Serological evidence of Ebola virus exposure in dogs from affected communities in Liberia: a preliminary report.
PLoS Neglected Tropical Diseases
2019
more details...
-
Medina LO, To A, Lieberman MM, Wong TAS, Namekar M, Nakano E, Andersen H, Yalley-Ogunro J, Greenhouse J, Higgs S, Huang YS, Vanlandingham DL, Horton JS, Clements DE, Lehrer AT.
A recombinant subunit based Zika virus vaccine is efficacious in non-human primates.
Frontiers in Immunology
2018
more details...
-
To A, Medina LO, Mfuh KO, Lieberman MM, Wong TAS, Namekar M, Nakano E, Lai CY, Kumar M, Nerurkar VR, Lehrer AT.
Recombinant Zika virus subunits are immunogenic and efficacious in mice.
mSphere
2018
more details...
-
Lai C-Y, Strange DP, Wong TAS, Lehrer AT, Verma S.
Ebola virus glycoprotein induces an innate immune response in vivo via TLR4.
Frontiers in Microbiology
2017
more details...
-
Lehrer AT, Wong TS, Lieberman MM, Humphreys T, Clements DE, Bakken RR, Hart MK, Pratt WD, Dye JM.
Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice.
Vaccine
2017
more details...
Grants
-
Grant No / Title: 1 U01GH002256-01 / Epidemiology and Immunity to Ebola Virus and Other Emerging Viral Infections in Liberia
Status / Agency: Awarded / Centers for Disease Control
Start Date / End Date: 30 September 2019 / 29 September 2024
-
Grant No / Title: R01AI132323 / Preclinical Development of a Thermostable Trivalent Filovirus Vaccine
Status / Agency: Awarded / NIH/NIAID
Start Date / End Date: 20 June 2017 / 31 May 2022
-
Grant No / Title: R01AI119185 / Defining a Protective Ebola Vaccine in Non-human Primates
Status / Agency: Awarded / NIH/NIAID
Start Date / End Date: 28 August 2015 / 31 July 2019
-
Grant No / Title: W81XWH-15-R-0015 / US Army Medical Research Institute of Infectious Diseases (USAMRIID) Requirement to Develop, Produce and Deploy MAGPIX-Based Immunoassays
Status / Agency: Awarded / Department of Defense, U.S. Army Medical Research Acquisitions Administration
Start Date / End Date: 13 July 2015 / 12 July 2017
|